GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

 1,795.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,901.50p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,075.43m
  • Volume: 0
  • Market Cap: £73,174m
  • RiskGrade: 129
  • Beta: 0.94

Latest Deals

Traded Action Notifier PriceAmountValue
14-Jan-26 Buy Dividends Hal Barron 1,871.05p 5,664 £105,976.17
08-Jan-26 Buy Dividends Luke Miels 1,894.33p 3 £56.83

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
14-Jan-26 Buy Dividends Hal Barron 1,871.05p 5,664 £105,976.17
08-Jan-26 Buy Dividends Luke Miels 1,894.33p 3 £56.83

Director Shareholdings

Notifier Holding Value*
Vishal Sikka 253,476,956 £4,551,178,745
Hal Barron 15,321,339 £275,094,642
Jonathan Symonds 71,193 £1,278,270
Charles Bancroft 67,008 £1,203,129
Julie Brown 44,444 £797,992
Anne Beal 7,780 £139,690
Harry (Hal) C. Dietz 6,206 £111,429
Elizabeth (Liz) McKee Anderson 4,679 £84,011
Wendy Becker 3,503 £62,896
Jeannie Lee 3,298 £59,216
Luke Miels 3 £54

Major Shareholders

Notifier** Holding Value*
Dodge & Cox 253,464,108 £4,550,948,059
Dodge & Cox 253,464,108 £4,550,948,059
BlackRock Inc 231,975,400 £4,165,118,307
GSK plc 197,068,169 £3,538,358,974
The Capital Group Companies, Inc. 159,068,073 £2,856,067,251
Legal & General Group Plc 95,878,187 £1,721,492,848

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,795.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,901.50p
52 Week Low 1,264.00p
Volume 0
Shares Issued 4,075.43m
Market Cap £73,174m
Beta 0.94
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q3 Q2
Ex-Div 13-Nov-25 14-Aug-25
Paid 08-Jan-26 09-Oct-25
Amount 16.00p 16.00p

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

GSK Key Personnel

CEO Luke Miels

Top of Page